Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP605321.RAayyGMwIkMNa7PH6emhjSza61M6cVx2ZDWUc2NT7gUgc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP605321.RAayyGMwIkMNa7PH6emhjSza61M6cVx2ZDWUc2NT7gUgc130_assertion type Assertion NP605321.RAayyGMwIkMNa7PH6emhjSza61M6cVx2ZDWUc2NT7gUgc130_head.
- NP605321.RAayyGMwIkMNa7PH6emhjSza61M6cVx2ZDWUc2NT7gUgc130_assertion description "[RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605321.RAayyGMwIkMNa7PH6emhjSza61M6cVx2ZDWUc2NT7gUgc130_provenance.
- NP605321.RAayyGMwIkMNa7PH6emhjSza61M6cVx2ZDWUc2NT7gUgc130_assertion evidence source_evidence_literature NP605321.RAayyGMwIkMNa7PH6emhjSza61M6cVx2ZDWUc2NT7gUgc130_provenance.
- NP605321.RAayyGMwIkMNa7PH6emhjSza61M6cVx2ZDWUc2NT7gUgc130_assertion SIO_000772 24098947 NP605321.RAayyGMwIkMNa7PH6emhjSza61M6cVx2ZDWUc2NT7gUgc130_provenance.
- NP605321.RAayyGMwIkMNa7PH6emhjSza61M6cVx2ZDWUc2NT7gUgc130_assertion wasDerivedFrom befree-20150227 NP605321.RAayyGMwIkMNa7PH6emhjSza61M6cVx2ZDWUc2NT7gUgc130_provenance.
- NP605321.RAayyGMwIkMNa7PH6emhjSza61M6cVx2ZDWUc2NT7gUgc130_assertion wasGeneratedBy ECO_0000203 NP605321.RAayyGMwIkMNa7PH6emhjSza61M6cVx2ZDWUc2NT7gUgc130_provenance.